Skip to Main Content

I built a transparent computational bridge from a genome-scale CD4⁺ T-cell Perturb-seq atlas (Marson–Pritchard CRISPRi, 4 donors, conditions Rest / Stim 8 h / Stim 48 h) to tumor spatial transcriptomics (CosMx NSCLC, 765,771 cells, 960-gene panel) to ask a two-part question: within a single annotated CD4⁺ T-cell type, do spatially distinct functional states exist, and can the Perturb-seq atlas nominate a different candidate regulator for each — respecting that a knockdown's effect depends on whether the T cell is resting or activated.

Team

Orca

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview